CRISPR Therapeutics appoints Siva Sakhamuri as chief technical officer
Sakhamuri's appointment took effect immediately on the day the company announced it, November 2, 2026.
GetSignal CRISPR Therapeutics AG CRSP
CRISPR Therapeutics said on November 2, 2026 that it has appointed Sivakesava (Siva) Sakhamuri, Ph.D., as chief technical officer, effective immediately.
Key facts
- Position
- Chief Technical Officer
- Effective
- Immediately
- Announced
- November 2, 2026
Source: The company's release on GlobeNewswire, November 2, 2026.
Written by GetSignal with AI from the company's press release.
Not investment advice.
